Podcasts about Obstetrics

For preterm prelabor rupture of membranes, the standard protocol for latency augmentation has remained IV amoxicillin and erythromycin for 2 days, followed by oral amoxicillin and erythromycin for 5 additional days. Nonetheless, azithromycinhas largely replaced erythromycin in PPROM management due to supply shortages and tolerability.  Previous retrospective studies (2019) have found no difference in latency between single-dose and multi-day azithromycin regimens, but these studies did not measure actual drugconcentrations at the site of action. In that 2019 retrospective study, there was also no difference in incidence of chorioamnionitis, or neonatal outcomes when comparing different dosing regimens of the azithromycin with erythromycin, with the exception of respiratory distress syndrome being more common in the 5 day azithromycin group. However, a 2024 single-center,retrospective study from Annals Pharmacotherapy found significantly higher rates of histologic chorioamnionitis with single-dose azithromycin compared to 5-day regimens(62.6% vs 46.4%, P=0.006), despite similar latency periods. So, it's complicated. A 2025 systematic review of international guidelines found that 6 out of 17 clinical practice guidelines acknowledged uncertainty about the optimal antibiotic regimen. This was published in the AJOG. In this episode, wewill review a new publication from March 2026 in the AJOG which sought to compare the pharmacokinetic parameters of 1 g once vs 500 mg daily dosing of azithromycin in the setting of preterm prelabor rupture of membranes and simulate various dosing regimens to identify the optimal regimen that maintains amniotic fluid concentration of azithromycin over the minimum inhibitory concentration of common GU pathogens associated with intraamniotic infection orinflammation. But there is a BIG limitation. Listen in for details. 1.    Navathe R, Schoen CN, Heidari P, Bachilova S, Ward A, Tepper J, Visintainer P, Hoffman MK, Smith S, Berghella V, Roman A. Azithromycin vs erythromycin for the management of preterm premature rupture of membranes. Am J Obstet Gynecol. 2019 Aug;221(2):144.e1-144.e8. doi: 10.1016/j.ajog.2019.03.009. Epub 2019 Mar 20.PMID: 30904320.2.    Kua S, Roman A, Harbinson L, Groom K, Whitehead C. Systematic review of nationaland international clinical practice guidelines for management of preterm prelabor rupture of membranes. Am J Obstet Gynecol. 2025 Nov 22:S0002-9378(25)00866-X. 3.    Day KN, Vircks JA, Henricks CE, Reaves KM, Holmes AK, Florio KL. Latency Antibiotics in Preterm Prelabor Rupture of Membranes: A Comparison of Azithromycin Regimens. Ann Pharmacother. 2024 Mar;58(3):234-240. doi:10.1177/10600280231181135. Epub 2023 Jun 26. PMID: 38124306.4.   Boelig, Rupsa C. et al. Azithromycin in preterm prematurerupture of membranes: population pharmacokinetics and dose optimization. AmericanJournal of Obstetrics & Gynecology, March 2026.  SPONSER SITE: Visit www.perspectivemedical for more information on the Hemorrhage View C-Section Drape

When Dr Leah Totton applied for The Apprentice, she was a full-time NHS doctor with no business experience and a clear career path ahead in Obstetrics and Gynaecology.She didn't expect to win.But winning meant walking away from certainty and stepping into the unknown with Lord Alan Sugar as her business partner.In this episode, I sit down with Leah to unpack what really happened after the cameras stopped rolling. The cash flow stress. The competitor who copied her business model before she even opened. The shock of realising that even after national TV exposure, nobody was queuing outside the clinic.This is the reality of building a service-based business.Leah shares the mindset shift from doctor to entrepreneur, the discipline of sector expertise, and why quality control matters more than rapid scale. We also dive into her seven-year journey to launch a skincare line that she refused to rush, despite pressure to “just put something out”.If you are thinking of starting a clinic, a product brand, or any service-led business, this conversation is a masterclass in resilience and execution.Key TakeawaysGetting customers is harder than launching: Opening the doors is easy. Building trust takes years. Especially in health and aesthetics.Sector expertise protects your business: If you cannot deliver the core service yourself, scaling becomes fragile.Thick skin is not optional: Business is not personal. The sooner you understand that, the faster you grow.Quality compounds: Short-term speed can damage long-term trust. Leah chose slower growth with stronger foundations.

Probiotics. They are often marketed as the end of all and be all for all our health issues. And they CAN do some real good. There is NO DOUBT a connection with overall heath and gut health…and NO ONE can deny that. But probiotics gets grey for some women's health issues. A new prospective, single-arm, non-blinded, multicenter study across 31 hospitals in Japan is making some pretty dramatic claims regarding oral probiotics and recurrent spontaneous preterm birth (ePUB). Can oral probiotics reduce spontaneous recurrent preterm birth? Listen in for details. 1. Prevention of Recurrent Spontaneous Preterm Delivery Using Probiotics: Results from a Prospective, Single-Arm, Multicenter Trial. PPP trial Collaborators et al.American Journal of Obstetrics & Gynecology, Volume 0, Issue 02. Grev J, Berg M, Soll R. Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev. 2018 Dec 12;12(12):CD012519. doi: 10.1002/14651858.CD012519.pub2. PMID: 30548483; PMCID: PMC6516999.3. Jarde A, Lewis-Mikhael AM, Moayyedi P, Stearns JC, Collins SM, Beyene J, McDonald SD. Pregnancy outcomes in women taking probiotics or prebiotics: a systematic review and meta-analysis. BMC Pregnancy Childbirth. 2018 Jan 8;18(1):14. doi: 10.1186/s12884-017-1629-5. PMID: 29310610; PMCID: PMC5759212.4. Othman M, Neilson JP, Alfirevic Z. Probiotics for preventing preterm labour. Cochrane Database Syst Rev. 2007 Jan 24;2007(1):CD005941. doi: 10.1002/14651858.CD005941.pub2. PMID: 17253567; PMCID: PMC9006117.5. Timing of Probiotic Milk Consumption During Pregnancy and Effects on the Incidence of Preeclampsia and Preterm Delivery: A Prospective Observational Cohort Study in Norway.6. Nordqvist M, Jacobsson B, Brantsæter AL, Myhre R, Nilsson S, Sengpiel V. Timing of probiotic milk consumption during pregnancy and effects on the incidence of preeclampsia and preterm delivery: a prospective observational cohort study in Norway. BMJ Open. 2018 Jan 23;8(1):e018021. doi: 10.1136/bmjopen-2017-018021. PMID: 29362253; PMCID: PMC5780685.7. Gao Q, Sun Y, Qu Y, Li F, Li P. The effect of probiotic supplementation during pregnancy on pregnancy complications: An umbrella meta-analysis. Medicine (Baltimore). 2025 Dec 19;104(51):e46409. doi: 10.1097/MD.0000000000046409. PMID: 41430994; PMCID: PMC12727282.SPONSOR WEBSITE: Visit perspectivemedical.org to learn more about the Hemorrhage View C-Section Drape

Happy International Women's Day 2026! In this special episode of the Coaching Podcast, Georgina talks all things Women's Health with a focus on paddling with her guest Dr Jagruti Amin (Jag) who has been a white water kayaker since 2013 and is a member of Paddle UK. It's an almost hour long whirlwind tour from the teenage years through to the menopause, with something in it for everyone. There's a crib sheet with resources and links available so you don't have to scribble them down. Jag is a GMC registered Dr (4645311) who qualified and started seeing patients in 1999 but had to give up her Licence to Practise in 2018 because of psoriatic arthritis. After studying medicine at the Universities of Cambridge and Oxford she started her career in hospitals training in medicine. She started specialist training in Haematology before deciding to move to the world of General Practice in 2006 which included a 6 month training post in Obstetrics and Gynaecology. As a fully fledged GP she had an interest in Women's Health, Contraception, Sexual Health and Safeguarding. For several years she also held separate roles as a Contraception and Sexual health Dr and a Named GP for Safeguarding Children. She was involved in medical politics as a representative on her Local Medical Council. Despite no longer seeing patients she's remained passionate about Women's Health and women advocating for themselves. A special thanks goes to Dr Kaye Brennan who is a GP, a Specialist Sports & Exercise Medicine Dr, a Council Member of the Faculty of Sports and Exercise Medicine and also works for the Ministry of Defence for her help and guidance in some of the more specialist areas in this podcast. The information provided in this podcast and the associated resources are current as of 26th February 2026. A reminder that the information is not individual medical advice and that any personal medical issues that come to light should be discussed with your own healthcare professional (such as a GP, Consultant, Specialist Nurse, Midwife, or Health Visitor). Dr Amin has not received any payment for this podcast, and is not sponsored by any organisation or company. All resources and links are current as of 26th February 2026 and are NOT to be used independently of the podcast. They do not constitute medical advice. All personal medical issues must be discussed with your own healthcare professional. To download the transcript for this episode click here. NHS Website: www.nhs.uk as a start for everything Women & Sport Women in Sport ‘Reframing Sport for Teenage Girls Tackling Teenage Disengagement' 2022 https://womeninsport.org/ wp-content/uploads/2022/03/2022-Reframing-Sport-for-Teenage-Girls-Tackling-Teenage-Disengagement.pdf Call it What it is Period https://thewell-hq.com/menstrual-cycle/calling-it-a-period-and-only-a-period-matters/ The Red Box Project https://redboxproject.org/ Also look at the British Rowing & British Swimming websites Nutrition Project RED-S red-s.com BEAT https://www.beateatiorg.uk/ UK Sports Institute Nutrition Guidelines https://uksportsinstico.uk/resource/sports-nutrition-fundamentals-to-improve-performance/ The British Dietetic Association https://www.bda.uk.com/resource/sport-exercise-nutritihtml NHS Vitamin D Guidance https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d/ All things Period, Contraception & Sexual Health Royal College of Obstetricians & Gynaecologists https://www.rcog.org.uk/for-the-public/browse-our-patient-information/ Brook https://www.brook.org.uk/ Women's Health Concern https://www.womens-health-concern.org/ National Association for Premenstrual Syndromes https://www.pms.org.uk/ A Young Person's Guide to Premenstrual Syndromes https://www.pms.org.uk/app/uploads/2021/09/A-Young-Persons-Guide-to-Premenstrual-Syndromes-8.pdf Polycystic Ovarian Syndrome https://www.verity-pcos.org.uk/ Endometriosis https://www.endometriosis-uk.org Contraception & Sexual Health COSRH https://www.contraceptiorg/ Sexual Health Clinic Information https://www.nhs.uk/live-well/sexual-health/ Menstrual Cycle Training & Injuries British Journal of Sports Medicine Blog 2025 https://blogs.bmj.com/bjsm/2025/11/03/can-the-menstrual-cycle-phase-impact-sports-performance/ UEFA Consensus Statement on Menstrual Cycle Tracking in Football 21st September 2025 https://bmjopensem.bmj.com/ content/11/3/e002769 Teenagers & Exercise Models used: The “Control–Capacity–Sport” model, The 4-Stage Youth Return-to-Sport Framework, The IOC “Youth Athlete Development Model”, Graduated loading principles (10% rule, staged impact progression) A non UK article from Sport New Zealand https://balanceisbettorg.nz/how-much-is-too-much-when-it-comes-to-youth-sport/ Pelvic Floor Pelvic Obstetrics & Gynaecology Physiotherapy https://thepogp.co.uk/patient_information/pelvic_health_advice.aspx Squeezy App £2.99 https://squeezyapp.com/women/about-squeezy-for-women/ Commercial devices with feedback Perifit & Elvie Pregnancy (In partnership with your healthcare professionals) International Olympic Committee https://stillmed.olympics.com/media/Documents/Athletes/Medical-Scientific/ Consensus-Statements/BJSM-Exercise-and-pregnancy-in-recreational-and-elite-athletes-Part-5-recommendations-for-health-professionals-and-active-women.pdf Pregnancy Continued (In partnership with your healthcare professionals) NHS Website https://www.nhs.uk/best-start-in-life/pregnancy/ UK Guidelines for Activity in Pregnancy https://assets.publishing.service.gov.uk/media/620a28288fa8f54916f45dfc/ physical-activity-for-pregnant-women.pdf & https://www.nhs.uk/pregnancy/keeping-well/exercise/   Faculty of Sports & Exercise Medicine (FSEM) Moving Medicine Patient Information https://movingmedicine.ac.uk/wp-content/uploads/2025/06/Pregnancy_Patipdf Active Pregnancy Foundation Questionnaire ‘Get Active Questionnaire for Pregnancy' https:// activepregnancyfoundation.org/_files/ugd/4c66ce_88e9ebbdad8748e7ab75d67815c76dcc.pdf Pelvic Obstetric & Gynaecological Physiotherapy https://thepogp.co.uk/patient_information/ pregnancy_and_early_postnatal.aspx Tommy's The Pregnancy & Baby Charity https://www.tommys.org/pregnancy-information/calculators-tools-resources UK Sport Pregnancy Guidance and Support for UK Sport Funded Athletes see the risk assessment for funded athletes https://www.uksport.gov.uk/resources/pregnancy-guidance The advice in this guidance is NOT for recreational athletes Maternal Mental Health NHS Advice https://www.nhs.uk/best-start-in-life/pregnancy/mental-health-and-pregnancy/ https://maternalmentalhealthalliance.org/about-maternal-mental-health/ Post Partum (In partnership with your healthcare professionals) NHS postpartum Exercise Information https://www.nhs.uk/baby/support-and-services/keeping-fit-and-healthy-with-a-baby/ Pelvic Obstetric & Gynaecological Physiotherapy https://thepogp.co.uk/patient_information/ pregnancy_and_early_postnatal.aspx FSEM Moving Medicine Post Partum Patient Information Leaflet https://movingmedicine.ac.uk/wp-content/uploads/ 2025/06/Post-partum_Patient_info_leaflet_2020-v2-1.pdf FSEM Moving Medicine Patient Information https://movingmedicine.ac.uk/wp-content/uploads/2025/06/Physical-activity-recommendations-post-natal.pdf FSEM Moving Medicine Patient Workbook https://movingmedicine.ac.uk/wp-content/uploads/2025/09/Patient-workbook-170925.pdf FSEM Moving Medicine Post Natal Pre Screening for Readiness Flowchart https://movingmedicine.ac.uk/wp-content/ uploads/2025/06/Flowchart.pdf Menopause National Institute for Clinical Excellence (NICE) Guidelines 2024 https://www.nice.org.uk/guidance/ng23/ informationforpublic The British Menopause Society https://thebms.org.uk/education/principles-practice-of-menopause-care/bms-ppmc-resources-toolkit/where-can-i-find-trusted-information-for-women-and-their-partners/ Women's Health Concern https://www.womens-health-concern.org/ Royal Osteoporosis Society https://theros.org.uk/information-and-support/bone-health/exercise-for-bones/how-to-build-up-exercise-for-your-bone-strength/ NHS Guidance for Exercise https://www.nhs.uk/live-well/exercise Diet & The Menopause https://www.womens-health-concern.org/wp-content/uploads/2023/06/31-WHC-FACTSHEET-Weight-Gain-and-menopause-JUNE2023-A.pdf Coaches Sport Scotland Free Learning Resources https://learning.sportscotland.org.uk/catalog?pagename=Work-with-female- athletes   Covering many of the subjects talked about in the podcast Women in Sport Podcasts https://womeninsport.org/explore-the-issues/podcast/ British Association of Sports & Exercise Medicine (BASEM) Podcasts & Female Athlete Health Page https://basem.co.uk/spotlight-on-sem-podcast-series/ Podcasts from Faculty of Sport & Exercise Medicine RED-S (2025) https://www.podbean.com/ew/pb-em4tt-17c642c   Sports Nutrition (2024) https://www.podbean.com/ew/pb-ba993-15b5940   Version 1. 26th February 2026 Dr Jagruti Amin GMC 4645311

Neither the ACOG nor SMFM recommend strict bed rest for preterm birth prevention, or nor preeclampsia. Yet tradition often conflicts with evidence. A prior 2009 survey of MFM specialists, published in the AJOG, on the use of bed rest revealed that 71% used activity restriction in their practice for arrested preterm labor, despite the majority believing it had minimal or no benefit. The authors concluded, “Because most obstetricians in our survey indicated they would prescribe bed rest believing it was associated with minimal or no benefit, it is possible that even if a randomized, prospective trial showed no benefit associated with bed rest, it would still remain a common recommendation.” This brings us to a brand new publication from the Green Journal which is an ancillary study of two randomized trials of preterm birth prevention in women with a short cervical length. These authors sought to evaluate the amount of physical activity in patients at high risk for preterm birth and pregnancy latency and preterm birth. What did they find? It is a bit shocking. Listen in for details.1. Fox, Nathan S. et al. The recommendation for bed rest in the setting of arrested preterm labor and premature rupture of membranes. American Journal of Obstetrics & Gynecology, Volume 200, Issue 2, 165.e1 - 165.e6 https://www.ajog.org/article/S0002-9378(08)00909-5/fulltext2. Sciscione, Anthony C. DO; Booker, Whitney A. for the Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units (MFMU) Network, Bethesda, Maryland. Activity Restriction in Pregnancy and the Risk of Early Delivery: The AWARE Study. Obstetrics & Gynecology ():10.1097/AOG.0000000000006225, February 19, 2026. | DOI: 10.1097/AOG.0000000000006225 https://journals.lww.com/greenjournal/pages/articleviewer.aspx?year=9900&issue=00000&article=01460&type=FulltextVisit our SPONSOR's Webpage for information on the Hemorrhage View C-Section Drape: www.perspectivemedical.org

The insights shared in this podcast episode underscore the importance of vigilance in healthcare settings. Recognizing red flags—whether they pertain to patient care, workplace culture, or system processes—can significantly enhance patient safety and care quality. By fostering a culture of awareness and prioritizing structured training methods like simulation, healthcare professionals can work towards creating safer environments for both patients and staff.The experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...

Welcome to Fertility and Sterility Roundtable, hosted by Dr. Emily Barnard and Dr. Ben Peipert! Each week, we will host a discussion with the authors of "Views and Reviews" and "Fertile Battle" articles published in a recent issue of Fertility and Sterility.  Today, we will be discussing the Fertile Battle from the February issue of Fertility and Sterility which is entitled "Should you do ultrasound monitoring and trigger for intrauterine insemination cycles? We are joined by two of the authors, Dr. Cassie Hobbs who will be taking the "pro" side in favor of ultrasound monitoring, and Dr. Lindsay Hartup, who will be arguing to do away with ultrasound monitoring.  Dr. Cassie Hobbs is a second-year Reproductive Endocrinology and Infertility fellow at the University of Pennsylvania. She completed her OB/GYN residency training at Brown University and received her medical degree from Duke University School of Medicine. She is passionate about examining disparities that exist in reproductive medicine and taking steps to make family building a more equitable process for all.  Dr. Lindsay Hartup is a Reproductive Endocrinology and Infertility fellow at Brigham and Women's Hospital. She completed medical school and Obstetrics and Gynecology residency at the University of Texas Health San Antonio. Her research interests are fertility preservation/oncofertility, assisted reproductive technology, and chronic endometritis. Read the Fertile Battle from Volume 125, Issue 2 p228-233 in the February 2026 issue View Fertility and Sterility at https://www.fertstert.org/  

Send a textIn this episode of Never Been Sicker, Michael Rubino talks with fertility specialist Dr. Robert Kiltz about why chronic illness and infertility feel more common than ever. Dr. Kiltz shares his perspective on modern nutrition advice, the role of inflammation, and why he believes animal fat, eating less often, and fasting can be powerful tools for health.They also dive into indoor air quality, mold, and how today's sealed homes and HVAC systems can trap particles and microbes, making it harder to feel your best. Dr. Kiltz explains why mindset, faith, and visualization matter, especially for women navigating infertility.

We explore what low amniotic fluid really means at different stages of pregnancy and when to act, when to watch, and how to personalise decisions. We share why routine induction for isolated low fluid may not improve outcomes and how to navigate monitoring, growth checks, and timing of birth.• defining oligohydramnios and anhydramnios• how gestation changes risk• ruling out ruptured membranes with history and tests• expert scans, infections, and maternal factors• why fluid matters for lung development• isolated low fluid late in pregnancy• induction evidence and unplanned caesarean risk• growth surveillance and timing around due date• continuous heartbeat monitoring considerations• practical reassurance and shared decision-makingWant to know more:https://obgyn.onlinelibrary.wiley.com/doi/10.1111/tog.70021Subscribe, rate, and review on your podcast app. Recommend The ObsPod to anyone who might find it interesting. Find the programme notes for links. Contact us on Twitter and Instagram @theObspod or email theObspod@gmail.com. If you can, support the show via Buy Me A Coffee.Thank you all for listening, My name is Florence Wilcock I am an NHS doctor working as an obstetrician, specialising in the care of both mother and baby during pregnancy and birth. If you have enjoyed my podcast please do continue to subscribe, rate, review and recommend my podcast on your podcast provider.If you have found my ideas helpful whilst expecting your baby or working in maternity care please spread the word & help theobspod reach other parents or staff who may be interested in exploring all things pregnancy and birth. Keeping my podcast running without ads or sponsorship is important to me. I want to keep it free and accessible to all but it costs me a small amount each month to maintain and keep the episodes live, if you wish to contribute anything to support theobspod please head over to my buy me a coffee page https://bmc.link/theobspodV any donation very gratefully received however small. Its easy to explore my back catalogue of episodes here https://padlet.com/WhoseShoes/TheObsPod I have a wide range of topics that may help you make decisions for yourself and your baby during pregnancy as well as some more reflective episodes on life as a doctor. If you want to get in touch to suggest topics, I love to hear your thoughts and ideas. You can find out more about me on Twitter @FWmaternity & @TheObsPod as well as Instagram @TheObsPod and e...

Women's health is at a pivotal moment in Ohio. From maternal care deserts and rising maternal mortality, to oncology advances and long-overdue conversations about menopause and postpartum mental health, this Columbus Metropolitan Club forum explores what our region is getting right—and where the system is still failing Ohio's women. Featuring Panelists: Jatu Boikai, Founder and CEO, Central Ohio Postpartum Extended Respite Center Dr. Kamilah Dixon, Director of the General Division of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center Dr. Shilpa Padia, Co-Medical Director of Oncology, Mount Carmel Health System Dr. Mona Prasad, System Chief, Maternal Fetal Medicine, OhioHealth Physicians Group Your host is Tracy Townsend, News Anchor and Medical Correspondent, WBNS 10TV. The presenting sponsors of CMC's long-running Optimal Health Series are Nationwide Children's Hospital, OhioHealth, and The Ohio State University Wexner Medical Center. This forum was also sponsored by Mount Carmel Health System. The presenting sponsor of the CMC livestream is The Center for Human Kindness at the Columbus Foundation. CMC's livestream partner is The Columbus Dispatch. This forum was also supported by Downtown Columbus, Inc. and The National Veterans Memorial and Museum. If you would like to keep exploring this week's forum topic, our partners at The Columbus Metropolitan Library recommend reading "The New Rules of Women's Health: Your Guide to Thriving at Any Age" by Meghan Rabbitt (2026). This forum was recorded before a live audience at the National Veterans Memorial and Museum in Columbus, Ohio on Wednesday, February 18, 2026.

We recently covered an SMFM abstract that was presented at the annual Pregnancy Meeting held in early February 2026. The authors were from my Alma Mater, UT Southwestern/Parkland Hospital. This was a well-done study comparing 162 milligrams aspirin to 81 milligrams of aspirin. The results were very encouraging! However, aspirin definitely has an awkward acumen. It would be wonderful if ALL the data just leaned in the same direction... but it doesn't! Enter our podcast family member, and my friend Alex. Alex sent me an incredible and insightful message which was a rebuttal to my Southwestern colleagues' findings. In this episode you'll hear Alex's rebuttal and clinical conundrum, and we will explain why these two seemingly paradoxical findings makes sense. Listen in for details.1. Khander, Amrin MD; Thomas, Charlene MS; Matthews, Kathy MD; Christos, Paul DrPH; Alcus, Claire BA; Alam, Tanvir BS; Bush, Leah BA; Deshmukh, Diksha BA; Chasen, Stephen T. MD; Riley, Laura E. MD; Skupski, Daniel W. MD; August, Phyllis MD, MPH; Malha, Line MD, MS. Comparison of 162 mg and 81 mg Aspirin for Prevention of Preeclampsia: A Randomized Controlled Trial. Obstetrics & Gynecology 147(1):p 87-96, January 2026. | DOI: 10.1097/AOG.0000000000006100

High-risk pregnancies are rising — and the need for specialized maternal care has never been greater.Dr. Kathryn Berryman, board-certified OBGYN and maternal-fetal medicine specialist, sits down with Allison Walsh and shares her journey from military physician to high-risk pregnancy expert serving women and families at AdventHealth for Women. After earning her medical degree at the University of Maryland and completing residency at Brooke Army Medical Center, she deployed to Iraq as an active-duty Army physician before pursuing fellowship training in maternal-fetal medicine at The Ohio State University.Today, Dr. Berryman cares for women navigating complex pregnancies, including medical complications, multiples, fetal concerns, and high-risk postpartum recovery. Her work extends beyond clinical care — she is deeply committed to teaching the next generation of physicians and advancing whole-person women's healthcare.This conversation explores:Why high-risk pregnancies are increasingWhat maternal-fetal medicine really meansThe future of prenatal testing — including genetics and proteomicsThe importance of postpartum and fourth trimester careHow telehealth is expanding access to specialized pregnancy careBalancing motherhood, marriage, and medicineThe role of confidence in high-achieving womenDr. Berryman's perspective blends clinical excellence, military service, and lived experience as a working mother — offering wisdom for women navigating both ambitious careers and family life. Learn more about women's healthcare services:https://adventhealthforwomen.com/ Connect with Dr. Kathryn Berryman:https://www.adventhealth.com/find-doctor/doctor/kathryn-berryman-md-1225249568 Connect with Allison:Instagram → @allisonwalshWork with Allison: Ready to turn your story into a service-driven brand that opens doors and expands your impact? 

Summary:In this episode of the Critical Care Obstetrics podcast, the hosts discuss the implications of a 'can-do' culture in healthcare, particularly in obstetrics. They explore how this attitude can lead to workarounds that, while initially well-intentioned, can negatively impact patient safety and staff well-being. The conversation delves into the importance of leadership in addressing these issues, the need for standardized assessments, and the dangers of normalizing deviations from best practices. The hosts emphasize the significance of clear roles during emergencies and the impact of burnout on healthcare professionals. They conclude with a call to action for team collaboration and empowerment to drive positive change in healthcare settings.The experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...

Exercise during pregnancy has long been encouraged, but clear guidance on what actually drives measurable physiological benefits has often been inconsistent. Episode 6 of The Research Debrief unpacks a newly published systematic review and meta-analysis from the American Journal of Obstetrics and Gynecology examining how structured exercise training during pregnancy impacts maternal biomarkers. The conversation moves beyond general outcomes and dives into what the latest science says about inflamation, metabolism, hormones and immune function — and what that means for fitness operators serving pregnant members. This Episode Explores: - A new systematic review and meta-analysis examining how exercise training during pregnancy impacts maternal biomarkers - Why combining aerobic and resistance training produces the strongest physiological benefits - How moderate to vigorous intensity exercise influences inflammatory, metabolic and hormonal markers - The importance of program duration — and why interventions longer than 12 weeks matter - Practical guidelines for structuring prenatal programs in health club settings This episode provides operators with evidence-based clarity on how to confidently program for pregnant members, highlighting that structured, longer-duration aerobic and strength training can positively influence key maternal health markers — creating opportunities for safe, strategic and science-backed prenatal offerings within clubs.

As BMIs and weights increase across the US population, there have been increased calls for universal screening for existing DM at entrance to prenatal care, if under 20 weeks. Others, including the ACOG, prefer to screen early those with additional risk factors (like prior GDM HX, prior macrosomia, BMI >30, PCOS, first degree relative with diabetes, or age >40). In July 2024, the ACOG released its publication, “Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum”. In this guidance, it states, “At this time, there are insufficient data to support the best screening modality for pregestational diabetes in pregnancy, but consideration can be made to use the same diagnostic criteria as for the nonpregnant population (A1c value 6.5 or higher, or fasting plasma glucose value 126 mg/dL or higher, or 2-hour plasma glucose value 200 mg/dL or higher during a 75-g OGTT, or random plasma glucose value 200 mg/dL or higher in patients with classic hyperglycemia symptoms)”. However, a new proposed protocol has been published in AJOG for early screening for DM in pregnancy. This also describes the differences in diagnosis and care for Standard GDM diagnosed at 24-28 weeks, vs a diagnosis of pregestational DM diagnosis made prior to 20-weeks vs “early” GDM also diagnosed under 20 weeks of gestation. Listen in for details. 1. McLaren, Rodney et al.nA Proposed Classification of Diabetes Mellitus in PregnancyAmerican Journal of Obstetrics & Gynecology, Volume 0, Issue 0. Epub Feb 2, 2026; https://www.ajog.org/article/S0002-9378(26)00061-X/fulltext2. ACOG Clinical Practice Update: Screening for Gestational and Pregestational Diabetes in Pregnancy and Postpartum; July 2024; https://journals.lww.com/greenjournal/abstract/2024/07000/acog_clinical_practice_update__screening_for.34.aspx3. Simmons, David et al. “Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy.” The New England journal of medicine vol. 388,23 (2023): 2132-2144. doi:10.1056/NEJMoa2214956

Learn how ACOG turns advocacy into action, supports clinicians, and creates community. Plus, get tips on how you can get involved. In this episode of BackTable OBGYN, Dr. Sivani Aluru from Endeavor Health in Chicago shares her journey and involvement with ACOG, from her medical school days to her current role as the national JFCAC Chair. --- SYNPOSIS Dr. Aluru describes her experiences on various task forces, including the ACOG 75th Anniversary Task Force, and emphasizes the importance of education, advocacy, and community within the organization. She offers insights into the challenges and benefits of participating in ACOG, provides tips for getting involved, and highlights the ongoing efforts to address critical issues in women's health. The conversation also touches on adapting to the changes brought by the COVID-19 pandemic and the value of staying organized and connected in a demanding field. Find out what ACOG is working on, how it benefits patient care, how it benefits provider education and resources, how it builds community. Get involved! Go to meetings! There are so many roles. If you don't get your role on the first go, try again. Showing up is huge! --- TIMESTAMPS 00:00 - Introduction03:41 - Residency and Early Involvement in ACOG07:29 - Advocacy and Government Affairs18:40 - Balancing Professional and Organizational Work24:28 - Listening to Members' Needs26:36 - Challenges and Value of ACOG Membership29:00 - The Importance of In-Person Meetings34:45 - ACOG's Legislative Advocacy and Future Plans35:48 - Advice for Getting Involved with ACOG40:16 - Conclusion --- RESOURCES ACOG (American College of Obstetricians and Gynecologists)https://www.acog.org/ ACOG CAARE Delegation https://www.acog.org/about/diversity-equity-and-inclusive-excellence/collective-action-strategy/caare-delegation ACOG CREOG (Council on Resident Education in Obstetrics and Gynecology) https://www.acog.org/education-and-events/creog/about

In this episode of Rounding@IOWA, Dr. Gerry Clancy sits down with breast cancer experts Dr. Katherine Huber‑Keener and Dr. Nicole Fleege for a discussion of modifiable and non‑modifiable risk factors, modern screening tools, and practical strategies clinicians can use to guide prevention and early detection. CME Credit Available:  https://uiowa.cloud-cme.com/course/courseoverview?P=0&EID=82146  Host: Gerard Clancy, MD Senior Associate Dean for External Affairs Professor of Psychiatry and Emergency Medicine University of Iowa Carver College of Medicine Guests: Nicole Fleege, MD Clinical Assistant Professor of Internal Medicine-Hematology, Oncology, and Blood and Marrow Transplantation University of Iowa Carver College of Medicine Kathryn Huber-Keener, MD PhD Clinical Associate Professor of Obstetrics and Gynecology - General Obstetrics and Gynecology University of Iowa Carver College of Medicine Financial Disclosures:  Dr. Gerard Clancy, his guests, and Rounding@IOWA planning committee members have disclosed no relevant financial relationships. Nurse: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this activity for a maximum of 0.75 ANCC contact hour. Pharmacist and Pharmacy Tech: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this knowledge-based activity for a maximum of 0.75 ACPE contact hours. Credit will be uploaded to the NABP CPE Monitor within 60 days after the activity completion. Pharmacists must provide their NABP ID and DOB (MMDD) to receive credit. JA0000310-0000-26-035-H99 Physician: The University of Iowa Roy J. and Lucille A. Carver College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other Health Care Providers: A certificate of completion will be available after successful completion of the course. (It is the responsibility of licensees to determine if this continuing education activity meets the requirements of their professional licensure board.)      

Guest: Lauren Osborne, M.D. Lauren Osborne, M.D., a reproductive psychiatrist at NewYork-Presbyterian and Weill Cornell Medicine and vice chair for clinical research for the Department of Obstetrics and Gynecology, discusses her research into the biological basis of postpartum depression. In a recent study, Dr. Osborne and her team were the first to analyze the entire metabolic pathway of progesterone, measuring both positive and negative allosteric modulators of the GABAA receptor throughout pregnancy and ultimately identifying a potential biomarker to predict risk. They are continuing to study and build upon these findings, with the goal of enabling better prediction and treatment options to address, or even prevent, postpartum depression. © 2026 NewYork-Presbyterian

In this episode, Dr. Margaret Larkins-Pettigrew, Professor and Academic Chair of Obstetrics and Gynecology at Drexel University School of Medicine, discusses closing gaps in maternal and child health, strengthening academic and healthcare partnerships, and addressing workforce shortages.

Our first VBAM (vaginal birth after myomectomy) was Episode 189 with Mabel back in 2022 and we are SO excited to finally be bringing you another! Maria Magdalena “Mags” Campbell joins us from Cape Town, South Africa to share her inspiring story through loss, fertility challenges, and ultimately TWO VBAM births.  With the support of Chinese medicine, acupuncture, progesterone, and a fertility coach, Mags went on to conceive her son naturally. She met with 8 doctors before finally finding a VBAM supportive provider and hospital at 32 weeks. After a successful ECV for a breech baby, she went on to have a hospital VBAM with an epidural at 9 cm at 40+1 weeks, welcoming her 3.9-kg son.Her second pregnancy came easily and felt very different. Mags prepped similarly with things like Chinese medicine and acupuncture, but leaned even more into holistic prep through breathwork, meditation, yoga, and doula support. Mags chose a hospital birth over a home birth and went on to have a euphoric, unmedicated vaginal water birth at 40+3 weeks, welcoming her 4.1-kg daughter.During her prep, Mags connected with Mabel and she hopes that her stories can bring the same inspiration that Mabel's did for her. We are also posting a new blog all about VBAM in honor of Mags' episode that you can find at www.thevbaclink.com/blog. American Journal of Obstetrics & Gynecology (AOGS)PubMed StudyEuropean Journal of Obstetrics & GynecologyJournal of Obstetrics and Gynaecology Canada (JOGCScienceDirect ReviewEpisode 189 Mabel's VBAM (Vaginal Birth After Myomectomy)Support this podcast at — https://redcircle.com/the-vbac-link/donationsAdvertising Inquiries: https://redcircle.com/brands

Pam Simon, MSN, CPNP, CPON, Stanford Adolescent and Young Adult Cancer Program (SAYAC), Palo Alto, CA and H. Irene Su, MD MSCE, University of California San Diego, San Diego, CA Recorded on January 20, 2026 Pam Simon, MSN, CPNP, CPON Nurse Practitioner & Program Manager Stanford Adolescent and Young Adult Cancer Program (SAYAC) Palo Alto, CA H. Irene Su, MD MSCE Professor Reproductive Endocrinology and Infertility Fellowship Director Division of Reproductive Endocrinology and Infertility Co-Director, Center for Obstetrics and Gynecology Research Innovations Department of Obstetrics, Gynecology and Reproductive Sciences Director, Moores Cancer Center Leadership Academy University of California San Diego San Diego, CA In this episode, we're joined by Dr. Irene Su, Professor of Obstetrics, Gynecology, and Reproductive Sciences at UC San Diego, and Pam Simon, Nurse Practitioner and Program Manager of the Stanford Adolescent and Young Adult (AYA) Cancer Program at Stanford Medicine. They discuss fertility risk across treatment types, approaches to fertility preservation and reproductive survivorship planning, insurance and access considerations, and the cultural and sociodemographic factors that shape care. They also share strategies to support shared decision-making and promote psychosocial well being for AYA patients and survivors. Tune in for practical insights to strengthen your approach to fertility care for AYAs. Mentioned on this episode: OncofertilityRisk.com The Alliance for Fertility Preservation Additional Blood Cancer United Resources: Blood Cancer United Accredited and Non-Accredited Healthcare Professional Education Blood Cancer United Resources for Patients

In this episode of the Critical Care Obstetrics podcast, Dr. Stephanie Martin and her colleagues discuss the concept of 'Can-Do Culture' in healthcare, particularly in obstetrics. They explore personal stories that illustrate the challenges and consequences of this mindset, especially regarding patient safety and staffing issues. The conversation emphasizes the importance of understanding the scope of service, the impact of a can-do attitude on patient outcomes, and the need for structured processes in healthcare settings. They also highlight the role of simulation as a tool for improving efficiency and problem-solving in clinical practice. The episode concludes with a call for further discussion on the implications of can-do culture on individual healthcare providers and the potential for burnout.The experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...

Join me and my guest Jamie Knopman, MD, a board certified reproductive endocrinologist and Director of Fertility Preservation for CCRM Fertility of New York. She is also Assistant Clinical Professor in Obstetrics and Gynecology at Mount Sinai Hospital. We explore the intersection of fertility, career-building, and personal agency and why equitable access to egg freezing is essential to gender equality in the workplace and beyond. Jamie brings not only deep clinical expertise, but also a culturally sharp, unapologetically feminist perspective on why women shouldn't have to choose between thriving professionally and preserving their future ability to have children. Nearly 70% of her patients today are freezing eggs before they face infertility. And companies such as Meta, Disney, and Amazon often cover the cost. She also highlights new pathways like egg-sharing programs that allow women to preserve their fertility at no cost, if they choose to donate a portion of their eggs. These trends reflect a cultural shift, and one she believes we urgently need to accelerate. SHOW NOTES  SPONSORED BY: Power of You! https://leader.blainebartlett.com/power-of-you Summary In this conversation, Blaine and Dr. Jamie Knopman discusses the evolving landscape of fertility, particularly focusing on egg freezing and embryo preservation. She highlights the importance of education and empowerment for women in making informed choices about their reproductive health. The discussion also touches on the emotional dynamics surrounding fertility, the role of companies in supporting women's choices, and future innovations in fertility medicine. Dr. Knopman emphasizes the need for a supportive work environment that recognizes the unique challenges women face in balancing career and family planning.   Takeaways The shift from infertility to fertility preservation is significant. Egg freezing allows women to maintain reproductive autonomy. Companies are increasingly offering fertility benefits to attract talent. Emotional dynamics play a crucial role in fertility decisions. Work-life balance requires planning and support systems. Education about fertility is essential for informed choices. Women are empowered to take charge of their reproductive health. Future innovations in fertility medicine are promising. The journey of life is fluid and not linear. Supportive work environments enhance women's contributions. Learn more about your ad choices. Visit megaphone.fm/adchoices

We have learned a lot about extended spectrum coverage of prophylactic antibiotics for cesarean section. The landmark C/SOAP trial randomized 2,013 women undergoing nonelective cesarean delivery to azithromycin 500 mg IV plus standard prophylaxis versus placebo, demonstrating a 51% reduction in the composite outcome of endometritis, wound infection, or other infection. Adjuvant Zmax (plus standard first-generation cephalosporin) is now recognized as evidence-based antibiotic coverage for intrapartum cesarean, cesarean with ruptured membranes, and patients with obesity. This last patient characteristic comes from the ERAS latest update. But what is ZMAX is not available? Is there an evidence-based peri-op alternative in these cases? Does Gent and Clinda cover mycoplasma/Ureaplasma? What about postop flagyl? Listen in for details. 1. Tita AT, Szychowski JM, Boggess K, et al. Adjunctive Azithromycin Prophylaxis for Cesarean Delivery. The New England Journal of Medicine. 2016. 2. Yang M, Yuan F, Guo Y, Wang S. Efficacy of Adding Azithromycin to Antibiotic Prophylaxis in Caesarean Delivery: A Meta-Analysis and Systematic Review. International Journal of Antimicrobial Agents. 2022. 2. ACOG Practice Bulletin No. 199: Use of Prophylactic Antibiotics in Labor and Delivery. Obstetrics and Gynecology. 2018. Committee on Practice Bulletins-Obstetrics 3. Martingano D, Nguyen A, Nkeih C, Singh S, Mitrofanova A. Clarithromycin Use for Adjunct Surgical Prophylaxis Before Non-Elective Cesarean Deliveries to Adapt to Azithromycin Shortages in COVID-19 Pandemic. PloS One. 2020. 4. Valent AM, DeArmond C, Houston JM, et al. Effect of Post–Cesarean Delivery Oral Cephalexin and Metronidazole on Surgical Site Infection Among Obese Women: A Randomized Clinical Trial. The Journal of the American Medical Association. 2017. 5. Wood, G. E., et al. "In Vitro Susceptibility of Mycoplasma genitalium to Nitroimidazoles." Antimicrobial Agents and Chemotherapy 6. https://www.cdc.gov/std/treatment-guidelines/mycoplasmagenitalium.htm

Dr. Peter Antevy returns to the Inside EMS co-host seat this week, filling in for Kelly Grayson and bringing some serious pediatric firepower to the conversation. Host Chris Cebollero dives right into the latest buzz around the Broselow tape recall — yes, again — as Dr. Antevy unpacks what went wrong, why it matters and what EMS agencies should be doing about it now. He also shares exciting details on his brand-new, field-focused Newborn Resuscitation & Obstetrics course (NROC), built by EMS for EMS. Designed with two hours of online content (zero PowerPoints!) and a short, in-house skills lab, this course aims to tackle one of the most nerve-wracking call types. No more dragging medics to the hospital for NRP classes that don't translate to street-level care. Also on deck: OB deserts, delayed cord clamping, why you might need to Saran-wrap a newborn (seriously), and what AI can — and can't — do for EMS. This one's packed with practical pearls, myth-busting insights and a whole lot of passion for pediatric education. Quotable takeaways from Dr. Peter Antevy “EMS is one specialty that AI will never take away, as far as like the human-to-human contact. We resuscitate people, we treat people who are seizing. AI will never do that. That's a good thing.” “Academics and the hospital folks don't recognize the value that EMS brings to the table. They think we're ambulance drivers. It's time for them to wake up and recognize that we are the people who deliver babies. We are the people who resuscitate grandma, grandpa and the little kid.” Enjoying Inside EMS? Email theshow@ems1.com to share feedback or suggest guests for future episodes. 

Dr. Rupsa Boelig, a 2025 March of Dimes Discovery Research Grant winner and an Associate Professor of Obstetrics and Gynecology in the Division of Maternal Fetal Medicine at Philadelphia's Thomas Jefferson University, discusses her new study on the metabolism of aspirin in pregnant women with diabetes or a higher BMI. She hopes the study findings will shed light on whether these women may benefit from a higher aspirin dose to help prevent preeclampsia and/or preterm birth.

As OB healthcare providers, we have several pieces of guidance regarding determination of amniotic fluid volume antepartum. The SMFM has Consult Series #46 (2018), which describes the management of polyhydramnios. We'll touch on that in this episode. However, while we have clear understanding of the increased risks of oligohydramnios, where an MVP is preferred for diagnosis over AFI, we have less information about polyhydramnios. But a new study published in BJOG (January 2026) provides more insights on this. While MVP is preferred for oligo diagnosis, can the same be said for polyhydramnios? Is there an increased risk in perinatal morbidity with polyhydramnios, and is that better detected by MVP or AFI? This new study findings left the authors unsatisfied although it CONFIRMED what we have covered in past episodes. Listen in for details.1. Dashe, Jodi S. et al. SMFM Consult Series #46: Evaluation and management of polyhydramnios. American Journal of Obstetrics & Gynecology, Volume 219, Issue 4, B2 - B8 (2018)2. ACOG PB 229: Antepartum Fetal Surveillance (2021)3. Petrecca A, Chauhan SP, Tersigni C, Ghi T, Berghella V. Amniotic Fluid Index Versus Maximum Vertical Pocket Versus Both for Polyhydramnios. BJOG. 2026 Jan 7. doi: 10.1111/1471-0528.70139. Epub ahead of print. PMID: 41502220.

Back in March of 2025, the green journal (obstetrics andgynecology) published A systematic review and meta-analysis on 2 medications (non-hormonal) and their efficacy in menopausal hot flash relief period these medications were Fezolinetant and Elinzanetant. However, the editors have just recently released an “Expression of Concern” about this review. Listen in for details. 1.     Menegaz de Almeida, Artur MS; Oliveira, PalomaMS; Lopes, Lucca MD; Leite, Marianna MS; Morbach, Victória MS; Alves Kelly,Francinny MD; Barros, Ítalo MS; Aquino de Moraes, Francisco Cezar MS;Prevedello, Alexandra MD. Fezolinetant and Elinzanetant Therapy for MenopausalWomen Experiencing Vasomotor Symptoms: A Systematic Review and Meta-analysis.Obstetrics & Gynecology 145(3):p 253-261, March 2025. | DOI:10.1097/AOG.00000000000058122.     Expression of Concern: Fezolinetant andElinzanetant Therapy for Menopausal Women Experiencing Vasomotor Symptoms: ASystematic Review and Meta-Analysis. Obstetrics & Gynecology():10.1097/AOG.0000000000006180, January 16, 2026. | DOI: 10.1097/AOG.0000000000006180

Implanon (etonogestrel implant) first received FDA approval in 2006, followed by the improved, radiopaque version, Nexplanon, approved by the FDA in 2010, which is now the only contraceptive implant available in the U.S. It was originally FDA approved for a 3-year use duration, although peer reviewed clinical data had demonstrated efficacy through year 5. Now, as of January 2026, the FDA has formally agreed to extend the label for 5-year use. In this episode, we will review the clinical data that prompted the FDA's decision, based on a multicenter, single-arm, open-label study evaluating contraceptive efficacy and safety during years 4 and 5 of implant use.1. https://www.contemporaryobgyn.net/view/fda-approves-5-year-use-for-etonogestrel-implant-68-mg-contraceptive2. Organon announces US Food and Drug Administration approval of supplemental new drug application extending duration of use of NEXPLANON (etonogestrel implant) 68 mg Radiopaque. Organon. Press release. January 16, 2026. Accessed January 19, 2026. https://www.organon.com/news/organon-announces-us-food-and-drug-administration-approval-of-supplemental-new-drug-application-extending-duration-of-use-of-nexplanon-etonogestrel-implant-68-mg-radiopaque/3. Ali M, Akin A, Bahamondes L, et al. Extended Use Up to 5 Years of the Etonogestrel-Releasing Subdermal Contraceptive Implant: Comparison to Levonorgestrel-Releasing Subdermal Implant. Human Reproduction. 2016. 4. McNicholas C, Swor E, Wan L, Peipert JF. Prolonged Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device: 2 Years Beyond Food and Drug Administration-Approved Duration. American Journal of Obstetrics and Gynecology. 2017. 5. McNicholas C, Maddipati R, Zhao Q, Swor E, Peipert JF. Use of the Etonogestrel Implant and Levonorgestrel Intrauterine Device Beyond the U.S. Food and Drug Administration-Approved Duration. Obstetrics and Gynecology. 2015.

What if maternal health goals expanded beyond "alive and healthy"? In honor of Maternal Health Awareness Day, Debra Pascali-Bonaro invites us to imagine a world where pregnancy, birth, and postpartum care are not only safe but also deeply respectful, emotionally whole, and infused with comfort and pleasure. In this moving solo episode, Debra shares her personal connection to the origins of Maternal Health Awareness Day—beginning in her home state of New Jersey—and explores how far the movement has come, and how far we still must go. With maternal mortality rates rising across the U.S. and nearly 80% of pregnancy-related deaths proven preventable, Debra calls us to collective action: to hold ground, raise our voices, and reclaim maternal health as a human right. From advocacy and policy to embodied care and global collaboration, this episode invites you to consider: what does it mean to move from surviving to thriving with safety, love, and pleasure? In this episode, you'll learn: The origins of Maternal Health Awareness Day and its urgent mission. Why systemic inequities—not personal failures—drive maternal mortality rates. How safety, equity, and pleasure are biologically connected in birth. The protective power of respect, love, and support during birth and postpartum. Practical advocacy steps for expectant parents, birth workers, and allies. Mentioned in this episode: International MotherBaby Childbirth Organization  @internationalmotherbabychi3946   International Childbirth Initiative (ICI)  @internationalchildbirthini2273   FIGO (International Federation of Gynecology and Obstetrics)  ICM (International Confederation of Midwives)  @WorldMidwives   American College of Obstetricians and Gynecologists (ACOG)   Eat Pray Doula Advanced Retreats www.eatpraydoula.com  Pleasurable Birth Essentials https://www.orgasmicbirth.com/pleasurable-birth-essentials Resources & Next Steps: Learn more and access free resources at https://www.orgasmicbirth.com/black-maternal-health-birth-equity-resources Share how you're holding ground on maternal health using #OrgasmicBirth and tag @orgasmicbirth on social media. Review and follow the show—we'd love to hear how this episode inspired you! Connect with Debra! Website: https://www.orgasmicbirth.com Instagram:   / orgasmicbirth  X:   / orgasmicbirth   YouTube    / orgasmicbirth1   Tik Tok   / orgasmicbirth   LinkedIn:   / debra-pascali-bonaro-1093471    ----

Decisions about family planning rarely happen in isolation. In the U.S., access to contraception, fertility care, and pregnancy-related services is shaped not only by individual choice, but by partners, families, employers, health care systems, and state policy—factors that can dramatically influence reproductive outcomes. Research consistently shows that social and structural conditions play a defining role in who can plan a pregnancy, delay one, or receive timely care. In the social domain of family planning, Kirtly Jones, MD, and Katie Ward, PhD, are joined by Jessica Sanders, PhD, assistant professor of Obstetrics and Gynecology and Director of Research at the ASCENT Center for Reproductive Health. Together, they explore how family planning decisions are shaped by layers of influence—from intimate partner dynamics and community access to poverty, misinformation, and shifting laws. The conversation examines how social forces enter even the most private decisions, and why understanding these pressures is essential for supporting truly informed, equitable reproductive care.

Ursodiol (ursodeoxycholic acid) is a prescription bile acid medication used to dissolve cholesterol gallstones, prevent gallstones during rapid weight loss, and treat liver diseases like primary biliary cholangitis (PBC) by reducing toxic bile acids and cholesterol production. It works by changing bile composition, making it less saturated with cholesterol, and is available as oral medication. Of course, it is also the foundational medication for treatment of diagnosed Intrahepatic Cholestasis of Pregnancy (ICP). Does this medication reduce adverse perinatal outcomes? In this episode, we will review a new study from the Green Journal, which will be out in February 2026, examining the recurrence risk for ICP using data from NY. In a patient with prior history of ICP, is there any guidance on monitoring of serum bile acids in the subsequent pregnancy before symptoms develop? We will explain. PLUS we will review the data on whether Ursodiol may hold promise in recurrence prevention or in reduction of adverse outcomes once the condition is diagnosed. Listen in for details. 1. 2019: Chappell LC, Bell JL, Smith A, Linsell L, Juszczak E, Dixon PH, Chambers J, Hunter R, Dorling J, Williamson C, Thornton JG; PITCHES study group. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet. 2019 Sep 7;394(10201):849-860. doi: 10.1016/S0140-6736(19)31270-X. Epub 2019 Aug 1. PMID: 31378395; PMCID: PMC6739598. https://pubmed.ncbi.nlm.nih.gov/31378395/2. February 08, 2025: Rahim, Mussarat N et al. Pregnancy and the liver. The Lancet. 2021; Volume 405, Issue 10477, 498 – 513 https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)02351-1/fulltext3. SMFM CS 53; 20214. Rosenberg, Henri M. MD; Sarker, Minhazur R. MD; Ramos, Gladys A. MD; Bianco, Angela MD; Ferrara, Lauren MD; DeBolt, Chelsea A. MD. Intrahepatic Cholestasis of Pregnancy Recurrence in a Subsequent Pregnancy. Obstetrics & Gynecology 147(2):p 239-241, February 2026. | DOI: 10.1097/AOG.0000000000006033 https://journals.lww.com/greenjournal/fulltext/2026/02000/intrahepatic_cholestasis_of_pregnancy_recurrence.13.aspx5. Ovadia C, Sajous J, Seed PT et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a systematic review and individual participant data meta-analysis. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):547-558. doi: 10.1016/S2468-1253(21)00074-1. Epub 2021 Apr 27. PMID: 33915090; PMCID: PMC8192305.6. EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy. European Association for the Study of the Liver; 2023

Feeling exhausted, foggy, short of breath, or just not like yourself during pregnancy and being told “that's normal”? This episode is for you. In Episode 417 of The Birth Lounge, HeHe sits down with OB/GYN PA and public health expert Kristy Goodman to talk about anemia in pregnancy and why it's so often overlooked, minimized, or brushed off until it becomes a much bigger issue. Together, they break down what anemia actually is, how and when it should be screened for, and why catching it early can completely change how you feel during pregnancy, labor, and postpartum. They explore how untreated anemia can impact energy levels, labor stamina, recovery, and overall well-being, and more importantly, what becomes possible when it's properly identified and treated with intention. Think more clarity, more strength, better healing, and the confidence to advocate for yourself instead of second-guessing your symptoms. Kristy brings an evidence-based, patient-centered lens to this conversation, helping listeners understand what labs matter, what questions to ask their provider, and how to push back when concerns are dismissed as “just part of pregnancy.” This episode is grounding, empowering, and deeply validating. If you've ever felt brushed off, unsure whether what you're feeling is normal, or just want to feel stronger and more supported in your body, this conversation will give you real tools and real answers.

Tara Eicher is a postdoctoral research fellow in the Department of Biostatistics at the Harvard T.H. Chan School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. T. Eicher, J. Quackenbush, and A. Ne'eman. Challenging Claims of an Autism Epidemic — Misconceptions and a Path Forward. N Engl J Med 2026;394:313-315.

The conversation also addresses the moral distress clinicians experience when a mother dies.This episode is for anyone who cares for pregnant or postpartum patients and wants to be better prepared—not just clinically, but emotionally and ethically—when the unthinkable happens. It is a reminder that even when we cannot save a life, how we care still matters profoundly.#MaternalMortality #MaternalHealth #MaternalDeath #PreventableDeaths #MaternalSafety #Postpartum #HighRiskPregnancy #MaternalHealthCrisis #HealthEquity #PerinatalCare #OBGYNThe experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...

Behind the Knife ABSITE 2026 – Up-to-date and high yield learning to help you DOMINATE the exam.Don't forget to check out our ABSITE Podcast Companion Book available on Amazon: https://www.amazon.com/Behind-Knife-ABSITE-Podcast-Companion/dp/B0CLDQWZG3/ref=monarch_sidesheetBe sure to check out our free study aid, which includes all 32 review episodes, brief written summaries, high yield images, and flash cards. Simply create an account on our iOS or Android app or on our website and you will find the entire course in your Library. Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Google Play App Store: https://play.google.com/store/apps/details?id=com.btk.appBehind the Knife would like to sincerely thank Medtronic for sponsoring the entire 2026 ABSITE podcast series.  Medtronic has a rich history of supporting surgical education, and we couldn't be happier that they chose to partner with Behind the Knife.  Learn more at https://www.medtronic.com/en-us/index.htmlIf you like the work that Behind the Knife is doing, please leave us a review wherever you listen to podcasts.  Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  Check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewBehind the Knife in Español - repaso para el examen de certificación en cirugía general: https://app.behindtheknife.org/premium/repaso-para-el-examen-de-certificaci-n-en-cirug-a-general

The ENG implant has data placing it as the most reversible, hormonal contraceptive agent available with a typical use failure rate of 0.05%. Unfavorable bleeding patterns, such as frequent or prolonged bleeding, affect approximately 40% of ENG implant users within the first 3 months but typically improve over time. Nonetheless, it is the main reason for patient discontinuation. In the past, various medications have shown to have at least some short-term reduction in bothersome breakthrough bleeding (BTB). These include doxycycline, ethinyl estradiol (EE), mefenamic acid, combined oral contraceptives (COCs), short term tamoxifen, norethindrone, and ulipristal acetate. In this episode, we will summarize a new RCT (AJOG, released as epub on Jan 7, 2026) which describes the use of TXA for ENG related BTB. Did it work? Listen in for details.1. Andrade, Maíra Cristina Ribeiro et al. Norethisterone for prolonged uterine bleeding associated with etonogestrel implant (IMPLANET): a randomized controlled trialAmerican Journal of Obstetrics & Gynecology, Volume 234, Issue 1, 101 - 1152. Edelman, Alison et al. Treatment of unfavorable bleeding patterns in contraceptive implant users with tranexamic acid: randomized clinical trial. American Journal of Obstetrics & Gynecology, Volume 0, Issue (Articles in Press January 07, 2026)

In vitro fertilization, or IVF, can cost upwards of $20,000 in California — for one cycle. For that reason, it's put financial strain on many California families and been completely out of reach for others, including couples who have faced insurance denials because they are LGBTQ+. But a California law that went into effect this month, SB 729, requires large employer-sponsored health plans to cover up to three cycles of IVF, along with other infertility services, regardless of sexual orientation. We'll hear what the new law means for family planning in California, and for you: Does this put IVF within reach for you? What's been your experience with IVF? Guests: Caroline Menjivar, member of the California State Senate representing the 20th district (San Fernando Valley) Shefali Luthra, reproductive health reporter, The 19th Sarah Jolly, has been trying to conceive with her husband for five years Dr. Alexander Quaas, medical director Shady Grove Fertility San Diego; fertility specialist; wrote an article for the American Journal of Obstetrics & Gynecology titled, “The California infertility insurance mandate: another step toward reproductive justice?” Learn more about your ad choices. Visit megaphone.fm/adchoices

If you go by pop culture depictions, menopause seems like no big deal — a few hot flashes, some comical bouts of hormone-fueled rage, and the “big change,” as it was once called, is over. But for many of the 2 million American women who enter menopause each year, the symptoms can be a lot more serious and long-lasting, ranging from vertigo and joint pain to brain fog and heart problems.On this episode, we take a deep dive into perimenopause and menopause – what's going on biologically? What can be done to ease symptoms? And why do so many women struggle to receive help from their doctors?We talk with menopause experts about hormone replacement therapy, and why it was demonized for many years; find out what researchers have discovered about the causes of brain fog; and hear about new efforts to deal with medically induced menopause. In this excerpt from our live event, Reimagining Menopause, host Maiken Scott talks with two certified menopause providers — Robyn Faye, an OB-GYN at Jefferson Health in Philadelphia, and Arina Chesnokova, assistant professor in of Obstetrics and Gynecology at the University of Pennsylvania's Perelman School of Medicine — about the ins and outs of hormone therapy, which symptoms it alleviates, when it's safe and when it's not. Watch the full discussion here. Reporter Alan Yu talks with researchers about what's behind one of the most vexing symptoms of menopause for many women — brain fog. For women who have cancer when they're younger, especially breast or ovarian cancer, chemotherapy and other medications needed to treat the disease can affect hormones - and suddenly plunge them into menopause, years before they might naturally experience it. We explore what their options are, and why so many say they were not prepared for this change.

A Podcast from Obstetrics & Gynecology highlighting the latest research and practice updates in the field. This episode features interviews with Drs. Amrin Khander and Line Malha, authors of "Comparison of 162 mg and 81 mg Aspirin for Prevention of Preeclampsia: A Randomized Controlled Trial," and Erin Chang and Dr. Emily S. Miller, authors of "Smartphone Applications to Support Perinatal Mental Health."

It's a controversial topic: the impact of uterine incision (hysterectomy) on the neonate delivery interval (also called the U-D interval). Does it matter? Just to be clear, we're talking about time from uterine entry to fetal extraction, not skin incision to fetal extraction. Past publications have produced conflicting results, often limited by small sample sizes, heterogeneous indications for delivery, and reliance on surrogate markers (like apgar scores) rather than clinical morbidity. But a new study published in the Gray journal at the end of 2025 (December 30, 2025) gives some new insights. In this episode, we will review this retrospective study and play the “Devil's advocate” as we summarize the rebuttal data. As the reports are conflicting, we will end the podcast with a real-world interpretation and application of this data. Listen in for details. 1. Bart, Yossi et al. Uterine Incision-to-Delivery Interval and Neonatal Outcomes among Non-urgent, Term, Cesarean Deliveries. American Journal of Obstetrics & Gynecology, Volume 0, Issue 0. https://www.ajog.org/article/S0002-9378(25)00980-9/fulltext?rss=yes2. Maayan-Metzger A, Schushan-Eisen I, Todris L, Etchin A, Kuint J. The effect of time intervals on neonatal outcome in elective cesarean delivery at term under regional anesthesia. Int J Gynaecol Obstet. 2010 Dec;111(3):224-8. doi: 10.1016/j.ijgo.2010.07.022. Epub 2010 Sep 19. PMID: 20855070. https://pubmed.ncbi.nlm.nih.gov/20855070/3. Spain JE, Tuuli M, Stout MJ, Roehl KA, Odibo AO, Macones GA, Cahill AG. Time from uterine incision to delivery and hypoxic neonatal outcomes. Am J Perinatol. 2015 Apr;32(5):497-502. doi: 10.1055/s-0034-1396696. Epub 2014 Dec 24. PMID: 25539409.4. Bader AM, Datta S, Arthur GR, Benvenuti E, Courtney M, Hauch M. Maternal and fetal catecholamines and uterine incision-to-delivery interval during elective cesarean. Obstet Gynecol. 1990 Apr;75(4):600-3. PMID: 2107478.5. Tekin, E., Inal, H.A. & Isenlik, B.S. A Comparison of the Effect of Time from Uterine Incision to Delivery on Neonatal Outcomes in Women with One Previous and Repeat (Two or More) Cesarean Sections. SN Compr. Clin. Med. 5, 80 (2023). https://doi.org/10.1007/s42399-023-01427-x

In this conversation, Dr. Tomer Singer shares his personal journey into reproductive medicine, influenced by his family's struggles with infertility. He discusses the unique challenges faced by Orthodox couples in fertility treatments and the importance of community engagement. The conversation also covers the rise of egg freezing as a viable option for women, the optimal age for freezing eggs, and the success rates of frozen eggs. Dr. Singer emphasizes the role of nutrition and AI in improving patient care and outcomes in reproductive medicine. He concludes with thoughts on the future of fertility treatments.Chapters00:00 The Journey into Fertility Medicine02:50 Understanding Orthodox Fertility Practices05:39 Navigating Religious and Medical Collaboration08:54 Education and Communication in Fertility11:40 The Rise of Egg Freezing15:01 Optimal Age for Egg Freezing17:58 Success Rates of Frozen Eggs20:39 Improving Egg Quality and Patient Health23:59 Future of Egg Freezing Technology29:51 Understanding the Costs of Egg Freezing32:59 The Importance of Egg Freezing for Future Fertility34:08 The Age Visit: A New Approach to Women's Health38:18 The Role of AI in Reproductive Medicine41:25 Job Security in the Age of AI45:23 Future Trends in Fertility Treatments48:46 Rapid Fire Questions on Fertility Practices52:28 Prioritizing Mental Health in a Busy Life54:25 Connecting with Dr. SingerAbout Dr. Tomer Singer:Tomer Singer, MD, MBA is an internationally renowned Endocrinologist and Infertility Specialist. He serves as the System Chief of Reproductive Endocrinology and Infertility at Northwell Health where he is responsible for programmatic strategy and fosters academic and clinical growth. Dr. Singer earned his medical degree from the Sackler School of Medicine and an MBA in Health Care Management from the Hofstra Zarb School of Business. He is double board- certified in Obstetrics and Gynecology and Reproductive Endocrinology and Infertility. He is an Associate Professor of OB/GYN at the Donald and Barbara Zucker School of Medicine. Dr. Singer has produced numerous publications, chapter reviews, and given presentations nationally and internationally in the field of Infertility, Reproductive Endocrinology, IVF, Pre-Implantation Genetic Testing (PGT), Egg Freezing, Egg Donation, and Gestational Surrogacy. He has performed hundreds of minimally invasive surgical procedures including laparoscopies and hysteroscopies. Dr. Singer has held several senior roles at Lenox Hill Hospital where he served as the Director of Reproductive Endocrinology and Infertility, the Vice Chairman of the Department of OB/GYN, Director of Egg Freezing, and the OB/GYN Residency Program Director. Dr. Singer's commitment to helping thousands of patients has earned him several awards including the Castle Conolly Top Doctor Award every year since 2017. Contact Dr. Tomer SingerInstagram @tsingermd

Doctors have long recommended regular cervical cancer screenings. Traditionally doctors perform these exams using a speculum, which often say is uncomfortable and, for many, quite painful. Some recent developments could make a large number of these screenings easier. In early January, the Health Resources and Services Administration, which is part of the Department of Health and Human Services, updated its guidelines to say that self-administered tests are an acceptable way to screen for human papillomavirus. HPV is a sexually-transmitted disease that causes the majority of cervical cancer cases. OB-GYNs are hopeful that at-home testing will make cervical cancer screenings easier to access…. and significantly more comfortable. Guests: Dr. Linda Eckert, professor of Obstetrics and Gynecology at the University of Washington School of Medicine Related links: New Guidelines Endorse Self-Swab Alternative to Pap Smear for Cervical Cancer Testing - The New York Times Cervical Cancer Risk Factors | Cervical Cancer | CDC The FDA has approved an at-home HPV test. What you need to know : NPR Thank you to the supporters of KUOW, you help make this show possible! If you want to help out, go to kuow.org/donate/soundsidenotes Soundside is a production of KUOW in Seattle, a proud member of the NPR Network.See omnystudio.com/listener for privacy information.

In this episode of Parts and Labor, Angela Chaudhari, MD, hosts a panel of experts from Northwestern Medicine's Division of Gynecologic Oncology to discuss the groundbreaking research and clinical trials shaping the future of gynecologic cancer care. The panel explores innovations in immunotherapy, investigator-initiated trials, survivorship and symptom science, while highlighting efforts to expand access and diversity in clinical research across Chicago and the surrounding suburbs.This episode's panel of guests includes:• Emma L. Barber, MD, John and Ruth Brewer Professor of Gynecology and Cancer Research, Division Chief of Gynecologic Oncology and Director of Robotic Surgery• Daniela E. Matei, MD, Diana, Princess of Wales Professor of Cancer Research and Chief of Reproductive Science in the Departments of Obstetrics and Gynecology and Hematology and Oncology• Dario R. Roque, MD, Associate Professor of Gynecologic Oncology and Fellowship Program Director• Emily M. Hinchcliff, MD, Assistant Professor of Gynecologic Oncology and Program Director of the OB-GYN Residency Program

Uterine rupture or dehiscence associated with TOLAC results in the most significant increase in the likelihood of additional maternal and neonatal morbidity. It should be noted that the terms “uterine rupture” and “uterine dehiscence” are not consistently distinguished from each other in the literature and often are used interchangeably. Furthermore, the reported incidence of uterine rupture varies in part because some studies have grouped true, catastrophic uterine rupture together with asymptomatic scar dehiscence. In January 2026, a new meta-analysis examines the relationship between oxytocin use with TOLAC and uterine rupture. In this episode, we will summarize the key findings in that study and review the data on the use of internal monitors during TOLAC. Do internal monitors (FSE, IUPC) offer a safer TOLAC compared with external monitors? Listen in for details.1. Nicolì, Pierpaolo et al.Oxytocin dosing during trial of labor after cesarean to minimize the risk of uterine rupture: a systematic review and meta-analysisAmerican Journal of Obstetrics & Gynecology MFM, Volume 8, Issue 1, 1018462. Practice Bulletin No. 184: Vaginal Birth After Cesarean Delivery. Obstetrics & Gynecology 130(5):p e217-e233, November 2017. | DOI: 10.1097/AOG.00000000000023983. ACOG Clinical Practice Guideline No. 10:Intrapartum Fetal Heart Rate Monitoring: Interpretation and Management. Obstetrics & Gynecology 146(4):p 583-599, October 2025. | DOI: 10.1097/AOG.00000000000060494. Bruno AM, Allshouse AA, Metz TD. Maximum Oxytocin Dose and Uterine Rupture During Trial of Labor After Cesarean. Obstet Gynecol. 2025 Dec 1;146(6):843-850. doi: 10.1097/AOG.0000000000006106. Epub 2025 Oct 30. PMID: 41325062.

In this episode of the Critical Care Obstetrics podcast, Dr. Stephanie Martin and Suzanne Baird discuss the sensitive and critical topic of maternal mortality. They share a case study of a young mother with chronic hypertension, exploring the clinical challenges and management decisions that led to her tragic outcome. The conversation delves into the importance of communication, support for families, and the need for healthcare professionals to address maternal death openly. They also highlight the alarming statistics surrounding maternal mortality in the U.S. and share personal experiences that underscore the emotional toll on healthcare providers. The episode aims to foster a deeper understanding of maternal health issues and the importance of compassionate care in the face of loss.The experts at Clinical Concepts in Obstetrics pool their decades of experience caring for critically ill pregnant women to discuss the challenges encountered in caring for these vulnerable women. Dr Stephanie Martin is the Medical Director for Clinical Concepts in Obstetrics and a Maternal Fetal Medicine specialist with expertise in critical care obstetrics. Suzanne McMurtry Baird, DNP, RN is the Nursing Director for Clinical Concepts in Obstetrics with many years of experience caring for critically ill pregnant women. Julie Arafeh, RN, MS is the Simulation Director for Clinical Concepts in Obstetrics and a leading expert in simulation.Critical Care Obstetrics Academy: https://www.clinicalconceptsinob.com/Follow us: Patreon: patreon.com/CCOB YouTube: @CriticalCareOBPodcast Instagram: https://www.instagram.com/criticalcareob/ Dr Martin's LinkedIn: http://linkedin.com/in/stephanie-martin-65b07112a CCOB LinkedIn: https://www.linkedin.com/company/clinical-concepts-in-obstetrics/ Twitter/X: https://twitter.com/OBCriticalCare CCOB Facebook: ...

In 2002, the National Institute of Child Health and Human Development (NICHD) proposed the 3-Tier fetal heart rate (FHR) classification system that was subsequently adopted by many organizations, categorizing tracings into three groups: Category I (normal), Category II (indeterminate), and Category III (abnormal). Recently, our podcast team received an interesting question form one of our podcast family members: “If there is a change in the fetal heart rate tracing intrapartum, but it is still in the normal range (like 120 going to 150)- and variability is normal, is that an abnormality? And what is meant by a ‘ZigZag' FHT pattern (different than marked variability)?”. That is a fantastically complex question…and we will explain the answer in this episode.1. Zullo F, Di Mascio D, Raghuraman N, Wagner S, Brunelli R, Giancotti A, Mendez-Figueroa H, Cahill AG, Gupta M, Berghella V, Blackwell SC, Chauhan SP. Three-tiered fetal heart rate interpretation system and adverse neonatal and maternal outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2023 Oct;229(4):377-387. doi: 10.1016/j.ajog.2023.04.008. Epub 2023 Apr 11. PMID: 37044237.2. Ghi T, Di Pasquo E, Dall'Asta A, et al. Intrapartum Fetal Heart Rate Between 150 and 160 BPM at or After 40 Weeks and Labor Outcome.Acta Obstetricia Et Gynecologica Scandinavica. 2021;100(3):548-554. doi:10.1111/aogs.14024.3. The 3 Tier System: chrome-extension://efaidnbmnnnibpcajpcglclefindmkaj/https://ncc-efm.org/filz/NICHD_Reference_from_CCPR.pdf4. Jia YJ, Ghi T, Pereira S, Gracia Perez-Bonfils A, Chandraharan E. Pathophysiological Interpretation of Fetal Heart Rate Tracings in Clinical Practice. American Journal of Obstetrics and Gynecology. 2023;228(6):622-644. doi:10.1016/j.ajog.2022.05.0235. Ghi T, Di Pasquo E, Dall'Asta A, et al. Intrapartum Fetal Heart Rate Between 150 and 160 BPM at or After 40 Weeks and Labor Outcome. Acta Obstetricia Et Gynecologica Scandinavica. 2021;100(3):548-554. doi:10.1111/aogs.14024.6. Yang M, Stout MJ, López JD, Colvin R, Macones GA, Cahill AG. Association of Fetal Heart Rate Baseline Change and Neonatal Outcomes. Am J Perinatol. 2017 Jul;34(9):879-886. doi: 10.1055/s-0037-1600911. Epub 2017 Mar 16. PMID: 28301895.

Podcast Family, in our immediate past episode we tackled the discrepancy that is often found between a clinical diagnosis of intra-amniotic infection/chorioamnionitis and histological chorioamnionitis. From that episode, we received a fantastic question from one of our podcast family members: Can a patient have IAI without fever? That question is really deep and highlights a gap in the current diagnostic scheme/ criteria from the ACOG. Listen in for details!1. ACOG CO 7122. Sukumaran S, Pereira V, Mallur S, Chandraharan E. Cardiotocograph (CTG) Changes and Maternal and Neonatal Outcomes in Chorioamnionitis and/­or Funisitis Confirmed on Histopathology. European Journal of Obstetrics, Gynecology, and Reproductive Biology. 2021. C3. Romero R, Chaemsaithong P, Korzeniewski SJ, et al. Clinical Chorioamnionitis at Term III: How Well Do Clinical Criteria Perform in the Identification of Proven Intra-Amniotic Infection? Journal of Perinatal Medicine. 2015.

My guest is Dr. Thaïs Aliabadi, MD, board-certified OB/GYN, surgeon and leading expert in women's health. We discuss polycystic ovary syndrome (PCOS) and endometriosis, two very common yet frequently undiagnosed causes of female infertility. Dr. Aliabadi explains the symptoms, underlying causes and evidence-based treatments for both conditions, including supplement and lifestyle interventions. We also discuss breast cancer risk and screening, pregnancy, perimenopause and menopause, and the hormone tests that women should request. This conversation offers empowering, potentially life-changing information for women of all ages to take control of their hormone, reproductive and overall health. Read the episode show notes at hubermanlab.com. Thank you to our sponsors AGZ by AG1: https://drinkagz.com/huberman Lingo: https://hellolingo.com/huberman Our Place: https://fromourplace.com/huberman Joovv: https://joovv.com/huberman LMNT: https://drinklmnt.com/huberman Function: https://functionhealth.com/huberman Timestamps 00:00 Thaïs Aliabadi 02:56 Why Endometriosis & Polycystic Ovary Syndrome (PCOS) Go Undiagnosed 08:16 Infertility, Tool: Early Screening 10:54 Sponsors: Lingo & Our Place 14:07 Women's Health Education Gap 15:24 PCOS Overview: Symptoms, Diagnosis, AMH, Disordered Eating 21:28 Irregular Periods, Teenage PCOS Diagnosis 24:36 Diagnosis, Pelvic Ultrasound; PCOS Naming 27:49 Thinning Hair & Acne; 4 PCOS Phenotypes; Mood & Treatment 35:54 Underlying Pillars of PCOS; HPA Axis, Androgens, Menstruation & Ovulation 40:30 Insulin Resistance & PCOS, Visceral Fat & Inflammation 46:30 Sponsors: AGZ by AG1 & Joovv 49:10 PCOS, Chronic Inflammation, Genetics & Lifestyle; Mood 52:31 PCOS, Fertility, Freezing Eggs, Tool: Egg Count & AMH Range By Age 58:34 Women's Health Education, AI, Clinicians; Cataracts Analogy 1:01:20 Stress; PCOS Treatment, Birth Control, Insulin Resistance & Metformin 1:06:44 PCOS Risk Calculator, Supplements, Lifestyle Factors; GLP-1s 1:12:32 Berberine, Metformin; GLP-1s, Food Anxiety & Alcohol 1:19:13 PCOS Prescriptions & Fertility; PCOS Co-Occurrence with Endometriosis 1:21:56 Sponsor: LMNT 1:23:16 PCOS Treatment, Freezing Eggs, Egg Quality; Advocate For Your Health 1:32:02 PCOS Key Takeaways: Symptoms, Tests, Supplements & Lifestyle 1:36:03 Undiagnosed Endometriosis, Fertility 1:39:26 Endometriosis: Symptoms, Diagnosis, Painful Periods, Infertility 1:42:30 Male vs Female Health Issues, Undiagnosed Endometriosis 1:47:01 Inflammation, Ectopic Implants, Chronic Pelvic Pain; Adenomyosis 1:50:36 Egg Quality, Endometriosis, Tools: Egg Counts; Pelvic Ultrasound 1:54:29 Sponsor: Function 1:56:13 Pain & Health Testing, Tool: Endometriosis Symptoms, Screening & Tests 2:01:32 Treatment, Surgery, Different Types of Endometriosis 2:05:22 Endometriosis Causes, Inflammation; Incidence, PCOS 2:11:58 Obstetrics & Gynecology Separation, Surgery 2:16:00 Endometriosis Key Takeaways: Symptoms, Treatment & Diagnosis 2:17:04 Treatment, Estrogen & Progesterone, Birth Control, GnRH Antagonists 2:22:39 Endometriosis Stage & Pain, Endometriosis Types 2:23:49 Pregnancy; Postpartum Depression, Menopause; Frustration for Patients 2:29:55 Fibroids, Surgery, Uterine Septum, Tool: Pelvic Ultrasound 2:34:05 Tool: Assessing Your & Partner's Fertility; Autoimmune Conditions 2:37:51 Breast Cancer, Tool: Lifetime Risk Calculator & Breast Imaging; Mastectomy 2:49:47 Endometriosis Tests, Autoimmune Disease; Brain Fog & Menopause; Inositol 2:53:06 Undiagnosed Infertility; PMDD Treatment; Fasting & Low-Carbohydrate Diets 2:57:21 Hair Loss & Perimenopause; Egg Quality; Endometriosis & Menopause 3:00:40 Increase Progesterone; Diet, Hormone & Menopause; Prolong Fertility 3:04:54 Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter Disclaimer & Disclosures Learn more about your ad choices. Visit megaphone.fm/adchoices